Emilie Ferrat1,2, Etienne Audureau3,4, Elena Paillaud3,5, Evelyne Liuu5, Christophe Tournigand6,7, Jean-Leon Lagrange8, Florence Canoui-Poitrine3,4, Philippe Caillet3,5, Sylvie Bastuji-Garin3,4,9. 1. Clinical Epidemiology and Ageing (CEpiA) Unit EA 7376, Université Paris Est (UPEC), A-TVB DHU, IMRB, F-94010 Créteil, France. emilie.ferrat@u-pec.fr. 2. Primary Care Department, Faculté de médecine, Université Paris Est, UPEC, F-94010 Créteil France. 3. Clinical Epidemiology and Ageing (CEpiA) Unit EA 7376, Université Paris Est (UPEC), A-TVB DHU, IMRB, F-94010 Créteil, France. 4. Department of Public Health, AP-HP, Hôpital Henri-Mondor, F-94010 Créteil, France. 5. Unité de coordination en oncogériatrie (UCOG), AP-HP, Hôpital Henri-Mondor, F-94010 Créteil, France. 6. Department of Medical Oncology, AP-HP, Hôpital Henri-Mondor, F-94010 Créteil, France. 7. Université Paris Est (UPEC), Early detection of Colon Cancer using Molecular Markers and Microbiota (EC2M3) Unit EA7375, UPEC, F-94010 Créteil, France. 8. Department of Radiation Oncology, AP-HP, Hôpital Henri-Mondor, F-94010 Créteil, France. 9. Clinical Research Unit (URC Mondor), AP-HP, Hôpital Henri-Mondor, F-94010 Créteil, France.
Abstract
BACKGROUND: Several studies have evaluated the independent prognostic value of impairments in single geriatric-assessment (GA) components in elderly cancer patients. None identified homogeneous subgroups. Our aims were to identify such subgroups based on combinations of GA components and to assess their associations with treatment decisions, admission, and death. METHODS: We prospectively included 1,021 patients aged ≥70 years who had solid or hematologic malignancies and who underwent a GA in one of two French teaching hospitals. Two geriatricians independently selected candidate GA parameters for latent class analysis, which was then performed on the 821 cases without missing data. Age, gender, tumor site, metastatic status, and inpatient versus outpatient status were used as active covariates and predictors of class membership. Outcomes were cancer treatment decisions, overall 1-year mortality, and 6-month unscheduled admissions. Sensitivity analyses were performed on the overall population of 1,021 patients and on 375 newly enrolled patients. RESULTS: We identified four classes: relatively healthy (LC1, 28%), malnourished (LC2, 36%), cognitive and mood impaired (LC3, 15%), and globally impaired (LC4, 21%). Tumor site, metastatic status, age, and in/outpatient status independently predicted class membership (p < .001). In adjusted pairwise comparisons, compared to LC1, the three other LCs were associated with higher risks of palliative treatment, death, and unscheduled admission (p ≤ .05). LC4 was associated with 1-year mortality and palliative treatment compared to LC2 and LC3 (p ≤ .05). CONCLUSION: We identified four health profiles that may help physicians select cancer treatments and geriatric interventions. Researchers may find these profiles useful for stratifying patients in clinical trials.
BACKGROUND: Several studies have evaluated the independent prognostic value of impairments in single geriatric-assessment (GA) components in elderly cancerpatients. None identified homogeneous subgroups. Our aims were to identify such subgroups based on combinations of GA components and to assess their associations with treatment decisions, admission, and death. METHODS: We prospectively included 1,021 patients aged ≥70 years who had solid or hematologic malignancies and who underwent a GA in one of two French teaching hospitals. Two geriatricians independently selected candidate GA parameters for latent class analysis, which was then performed on the 821 cases without missing data. Age, gender, tumor site, metastatic status, and inpatient versus outpatient status were used as active covariates and predictors of class membership. Outcomes were cancer treatment decisions, overall 1-year mortality, and 6-month unscheduled admissions. Sensitivity analyses were performed on the overall population of 1,021 patients and on 375 newly enrolled patients. RESULTS: We identified four classes: relatively healthy (LC1, 28%), malnourished (LC2, 36%), cognitive and mood impaired (LC3, 15%), and globally impaired (LC4, 21%). Tumor site, metastatic status, age, and in/outpatient status independently predicted class membership (p < .001). In adjusted pairwise comparisons, compared to LC1, the three other LCs were associated with higher risks of palliative treatment, death, and unscheduled admission (p ≤ .05). LC4 was associated with 1-year mortality and palliative treatment compared to LC2 and LC3 (p ≤ .05). CONCLUSION: We identified four health profiles that may help physicians select cancer treatments and geriatric interventions. Researchers may find these profiles useful for stratifying patients in clinical trials.
Authors: Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew Journal: J Clin Oncol Date: 2011-08-01 Impact factor: 44.544
Authors: Sergio Starkstein; Milan Dragovic; Ricardo Jorge; Simone Brockman; Marcelo Merello; Robert G Robinson; David Bruce; Mark Wilson Journal: Mov Disord Date: 2011-07-07 Impact factor: 10.338
Authors: Frederic Di Fiore; Stephane Lecleire; Olivier Rigal; Marie-Pierre Galais; Emmanuel Ben Soussan; Isabelle David; Bernard Paillot; Jacques-Henri Jacob; Pierre Michel Journal: World J Gastroenterol Date: 2006-07-14 Impact factor: 5.742
Authors: Asha Mathew; Amit Jiwan Tirkey; Hongjin Li; Alana Steffen; Mark B Lockwood; Crystal L Patil; Ardith Z Doorenbos Journal: Semin Oncol Nurs Date: 2021-09-03 Impact factor: 3.527
Authors: Thiago Morelli; Kevin L Moss; James Beck; John S Preisser; Di Wu; Kimon Divaris; Steven Offenbacher Journal: J Periodontol Date: 2016-09-13 Impact factor: 6.993
Authors: Heidi D Klepin; Can-Lan Sun; David D Smith; Rawad Elias; Kelly M Trevino; Ashley Leak Bryant; Daneng Li; Christian Nelson; William P Tew; Supriya G Mohile; Ajeet Gajra; Cynthia Owusu; Cary Gross; Stuart M Lichtman; Vani V Katheria; Hyman B Muss; Andrew E Chapman; Harvey Jay Cohen; Arti Hurria; William Dale Journal: JCO Oncol Pract Date: 2021-04-21
Authors: M D Torregrosa-Maicas; S Del Barco-Berrón; A Cotes-Sanchís; L Lema-Roso; S Servitja-Tormo; R Gironés-Sarrió Journal: Clin Transl Oncol Date: 2022-02-01 Impact factor: 3.340